Zacks Investment Research on MSN
Amgen Inc. (AMGN) is a trending stock: Facts to know before betting on it
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Amgen Inc. (NASDAQ:AMGN) has ...
On December 12, Morgan Stanley cut its price target for Amgen Inc. (NASDAQ:AMGN) from $329 to $304, but kept its Equal Weight rating.
Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best ...
Amgen Inc. (NASDAQ:AMGN) is a global biotechnology company recognised for its focus on biologic medicines addressing serious ...
Molly Bohannon has been a Forbes news reporter since 2023. The Federal Trade Commission filed a lawsuit Tuesday to block Amgen Inc. from purchasing Horizon Therapeutics for $27.8 billion, out of ...
Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results